Nanwei Medical announced that on April 14, 2025, the company received a “Letter on Proposing Nanwei Medical Technology Co., Ltd. to repurchase the company's public stock shares through centralized bidding transactions” from Chairman Long Xiaohui. The main contents of the proposal are as follows: the types and methods of repurchasing shares are to buy back the company's issued RMB common shares through the Shanghai Stock Exchange stock trading system; the repurchase of shares is used as an equity incentive or employee shareholding plan; the total repurchase capital is not less than RMB 30 million, not more than RMB 50 million; the price of the repurchase of shares does not exceed 150% of the average trading price of the company's shares in the 30 trading days before the board of directors passes the share repurchase decision; the source of the repurchase capital is the company's own funds.

Zhitongcaijing · 5d ago
Nanwei Medical announced that on April 14, 2025, the company received a “Letter on Proposing Nanwei Medical Technology Co., Ltd. to repurchase the company's public stock shares through centralized bidding transactions” from Chairman Long Xiaohui. The main contents of the proposal are as follows: the types and methods of repurchasing shares are to buy back the company's issued RMB common shares through the Shanghai Stock Exchange stock trading system; the repurchase of shares is used as an equity incentive or employee shareholding plan; the total repurchase capital is not less than RMB 30 million, not more than RMB 50 million; the price of the repurchase of shares does not exceed 150% of the average trading price of the company's shares in the 30 trading days before the board of directors passes the share repurchase decision; the source of the repurchase capital is the company's own funds.